ORAPRED Side Effects

5401914-6 | Blood Creatine Phosphokinase Increased, Dysstasia, Electrocardiogram Normal, Extrasystoles, Fatigue, Gait Disturbance, Hypokalaemia, Myalgia, Paralysis
on Jul 11, 2007 Male patient from FRANCE , 19 years of age, was treated with Orapred (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, dysstasia, electrocardiogram normal, extrasystoles, fatigue, gait disturbance, hypokalaemia, myalgia, paralysis (What is paralysis?). Orapred dosage: . Patient was hospitalized.

5295952-4 | Abnormal Behaviour, Blood Glucose Increased, Breath Sounds Abnormal, Phaehyphomycosis
Patient was taking Orapred (View Usage). Patient had the following side effects: abnormal behaviour, blood glucose increased, breath sounds abnormal, phaehyphomycosis on Mar 17, 2007 from INDIA Additional patient health information: Male patient , 40 years of age, was diagnosed with asthma (What is asthma?) and. Orapred dosage: Qd; Po. Patient was hospitalized.

4954438-4 | B-cell Lymphoma, Bedridden, Blood Pressure Decreased, Dehydration, Dilatation Ventricular, Dyspnoea Exertional, Embolism Venous, Mobility Decreased
Adverse event was reported on Mar 07, 2006 by a Female patient taking Orapred (View Usage) (Dosage: 60 Mg, Qd, Oral) was diagnosed with paraneoplastic syndrome and. Location: JAPAN , 67 years of age, After Orapred was administered, patient had the following side effects: b-cell lymphoma, bedridden, blood pressure decreased, dehydration, dilatation ventricular, dyspnoea exertional, embolism venous, mobility decreased.

4666452-7 | Agitation, Atelectasis, Dyspnoea Exacerbated, Flushing, Pneumonia, Pruritus, Respiratory Rate Increased, Swelling Face, Urticaria
on May 04, 2005 Female patient from , weighting 22.05 lb, was diagnosed with bronchospasm and was treated with Orapred (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, atelectasis, dyspnoea exacerbated, flushing, pneumonia (What is pneumonia?), pruritus, respiratory rate increased, swelling face, urticaria. Orapred dosage: 2 Mg/kg, Once, Po. During the same period patient was treated with MONTELUKAST SODIUM (View Montelukast Sodium Review and Montelukast Sodium Label ), ALBUTEROL SULFATE HFA (View Albuterol Sulfate Hfa Review and Albuterol Sulfate Hfa Label ).


4661057-6 | Agitation, Anaphylactic Reaction, Flushing, Respiratory Rate Increased
on Apr 26, 2005 Male patient from , weighting 22.05 lb, was diagnosed with bronchospasm and was treated with Orapred (View Usage). Patient had the following side effects: agitation, anaphylactic reaction, flushing, respiratory rate increased. Orapred dosage: 2 Mg/kg, Once, Po. During the same period patient was treated with MONTELUKAST SODIUM (View Montelukast Sodium Review and Montelukast Sodium Label ), SALBUTAMOL SULFATE (View Salbutamol Sulfate Review and Salbutamol Sulfate Label ).

4604039-2 | Abnormal Behaviour, Affect Lability, Crying, Screaming, Sleep Disorder
Patient was taking Orapred (View Usage). After Orapred was administered, patient had the following side effects: abnormal behaviour, affect lability, crying, screaming, sleep disorder (What is sleep disorder?) on Mar 08, 2005 from Additional patient health information: Male patient , weighting 25.00 lb, was diagnosed with asthma (What is asthma?), bronchiectasis and. Orapred dosage: 4 Ml Daily X 5 Days Oral.

4599393-4 | Abnormal Behaviour, Aggression, Personality Change, Psychomotor Hyperactivity
Adverse event was reported on Mar 03, 2005 by a Female patient taking Orapred (View Usage) (Dosage: 1/2 Tsp A Da For 2 Days Oral) . Location: , weighting 23.00 lb, Patient experienced the following unwanted or unexpected effects: abnormal behaviour, aggression, personality change, psychomotor hyperactivity.